IOF vs. TET, SYNT, ZTF, WCH, ITX, DCTA, BIOM, HAYD, HDD, and VRS
Should you be buying Iofina stock or one of its competitors? The main competitors of Iofina include Treatt (TET), Synthomer (SYNT), Zotefoams (ZTF), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), Directa Plus (DCTA), Biome Technologies (BIOM), Haydale Graphene Industries (HAYD), Hardide (HDD), and Versarien (VRS). These companies are all part of the "specialty chemicals" industry.
Iofina vs.
Treatt (LON:TET) and Iofina (LON:IOF) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, community ranking, media sentiment, analyst recommendations and institutional ownership.
Treatt has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500. Comparatively, Iofina has a beta of 0.71, suggesting that its stock price is 29% less volatile than the S&P 500.
Treatt has a net margin of 7.88% compared to Iofina's net margin of 6.98%. Treatt's return on equity of 8.09% beat Iofina's return on equity.
In the previous week, Iofina had 1 more articles in the media than Treatt. MarketBeat recorded 1 mentions for Iofina and 0 mentions for Treatt. Treatt's average media sentiment score of 0.00 equaled Iofina'saverage media sentiment score.
Treatt has higher revenue and earnings than Iofina. Treatt is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks.
Iofina received 36 more outperform votes than Treatt when rated by MarketBeat users. However, 68.97% of users gave Treatt an outperform vote while only 66.44% of users gave Iofina an outperform vote.
50.9% of Treatt shares are held by institutional investors. Comparatively, 6.4% of Iofina shares are held by institutional investors. 13.4% of Treatt shares are held by company insiders. Comparatively, 45.1% of Iofina shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Treatt presently has a consensus target price of GBX 650, indicating a potential upside of 154.90%. Iofina has a consensus target price of GBX 36.25, indicating a potential upside of 55.58%. Given Treatt's higher probable upside, analysts plainly believe Treatt is more favorable than Iofina.
Summary
Treatt beats Iofina on 11 of the 16 factors compared between the two stocks.
Get Iofina News Delivered to You Automatically
Sign up to receive the latest news and ratings for IOF and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (LON:IOF) was last updated on 5/1/2025 by MarketBeat.com Staff
